CStone Pharmaceuticals carries a market capitalization of 8.27B, placing it among publicly traded companies globally.
| Market Cap | 8.27B |
| Enterprise Value | N/A |
CStone Pharmaceuticals's stock has declined approximately -0.19305019% over the past 52 weeks. The 50-day moving average sits at 6.67, while the 200-day moving average is 6.63.
| Beta (5Y) | N/A |
| 52-Week Price Change | -0.19305019% |
| 50-Day Moving Average | 6.67 |
| 200-Day Moving Average | 6.63 |
| Average Volume (20 Days) | N/A |